| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 免疫系统用药(元) | 75,676,074.80 | 169,446,937.34 | 100,824,930.92 | 358,200,302.12 | 185,458,599.80 |
| 神经系统用药(元) | 19,905,253.56 | 55,791,757.17 | 34,971,571.57 | 76,862,005.38 | 38,114,651.13 |
| 心脑血管用药(元) | 116,755,907.69 | 247,503,871.90 | 129,954,762.53 | 294,141,952.26 | 155,632,651.30 |
| 其他(元) | 2,499,682.73 | 3,827,015.30 | 6,286,499.07 | 5,342,592.83 | 4,137,006.84 |
| 营业成本(元) | |||||
| 免疫系统用药(元) | 29,182,470.67 | 60,132,284.65 | 28,147,037.78 | 83,635,972.48 | 42,452,077.93 |
| 神经系统用药(元) | 11,780,890.03 | 27,702,405.95 | 16,616,236.38 | 24,993,724.88 | 14,644,862.52 |
| 心脑血管用药(元) | 30,505,618.08 | 50,245,594.60 | 28,648,301.58 | 58,886,440.93 | 30,109,456.74 |
| 其他(元) | 2,533,076.03 | 2,859,029.13 | 3,014,722.60 | 4,091,404.02 | 1,605,715.66 |
| 毛利(元) | |||||
| 免疫系统用药(元) | 46,493,604.13 | 109,314,652.69 | 72,677,893.14 | 274,564,329.64 | 143,006,521.87 |
| 神经系统用药(元) | 8,124,363.53 | 28,089,351.22 | 18,355,335.19 | 51,868,280.50 | 23,469,788.61 |
| 心脑血管用药(元) | 86,250,289.61 | 197,258,277.30 | 101,306,460.95 | 235,255,511.33 | 125,523,194.56 |
| 其他(元) | -33,393.30 | 967,986.17 | 3,271,776.47 | 1,251,188.81 | 2,531,291.18 |
| 毛利率(%) | |||||
| 免疫系统用药(%) | 61.44 | 64.51 | 72.08 | 76.65 | 77.11 |
| 神经系统用药(%) | 40.82 | 50.35 | 52.49 | 67.48 | 61.58 |
| 心脑血管用药(%) | 73.87 | 79.70 | 77.96 | 79.98 | 80.65 |
| 其他(%) | -1.34 | 25.29 | 52.04 | 23.42 | 61.19 |
| 收入构成(%) | |||||
| 免疫系统用药(%) | 35.22 | 35.56 | 37.06 | 48.76 | 48.38 |
| 神经系统用药(%) | 9.27 | 11.71 | 12.86 | 10.46 | 9.94 |
| 心脑血管用药(%) | 54.35 | 51.93 | 47.77 | 40.04 | 40.60 |
| 其他(%) | 1.16 | 0.80 | 2.31 | 0.73 | 1.08 |
| 毛利构成(%) | |||||
| 免疫系统用药(%) | 33.01 | 32.57 | 37.15 | 48.77 | 48.55 |
| 神经系统用药(%) | 5.77 | 8.37 | 9.38 | 9.21 | 7.97 |
| 心脑血管用药(%) | 61.24 | 58.77 | 51.79 | 41.79 | 42.62 |
| 其他(%) | -0.02 | 0.29 | 1.67 | 0.22 | 0.86 |